Google Foundation's Predict and Prevent Initiative

google.orgPredict and Prevent aims to strengthen traditional disease surveillance and response, but Google.org also hope to foster thinking about what we can do to predict threats before they occur and focus on prevention. In partnership with others, will be enabled a rapid and effective response to emerging threats by improving detection and validation, and establishing better systems for early warning. At the same time the initiative will build the science, technology, and capacity in the developing world to map regions vulnerable to future outbreaks. The result of this will be to shift the point of response down the outbreak curve thereby shifting the nature of response from reactive to proactive.

To provide effective early warning of an emerging disease threat, a community first has to detect the threat and confirm the infectious agent. Google.org will support better detection, rapid validation, and early warning mechanisms to enable a timely and appropriate response. The success of these efforts will depend on having basic epidemiology and laboratory capacity throughout the world and the willingness to openly share important data for disease control and prevention.

In short, Google.org will focus on:

  • Using innovative methods to quickly find threats wherever they occur
  • Confirming outbreaks and identifying their cause
  • Engaging key stakeholders, from villagers to global health authorities

For further information, please visit:
http://www.google.org

About Google.org
In 2004, when Google founders Larry Page and Sergey Brin wrote to prospective shareholders about their vision for the company, they outlined a commitment to contribute significant resources, including 1% of Google's equity and profits in some form, as well as employee time, to address some of the world's most urgent problems. That commitment became Google.org.

Most Popular Now

Making Cancer Vaccines More Personal

In a new study, University of Arizona researchers created a model for cutaneous squamous cell carcinoma, a type of skin cancer, and identified two mutated tumor proteins, or neoantigens, that...